article thumbnail

Why radiopharmaceuticals are gaining ground in the fight against cancer

Drug Target Review

In an interview with our team, Delpassand shared his perspective on how targeted radiopharmaceuticals are reshaping cancer treatment and what lies ahead for this evolving field. Prior treatments and patient histories often introduce variables that can affect outcomes, making thoughtful trial design essential for generating reliable data.

Therapies 100
article thumbnail

Scientific workflow for hypothesis testing in drug discovery: Part 1

Drug Target Review

In cases where control or treatment groups show large variability, this could reflect true biological responses to a treatment, and removing such data could reduce the accuracy of the analysis. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry.

RNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The next phase of the multiomics evolution, powered by AI

Drug Target Review

In 2003, the completion of the Human Genome Project was celebrated as the start of a new era in medicine. Combined with rigorous experimental design and high-fidelity data collection, this approach could unlock faster therapeutic cycles, better predictive models for clinical success and more personalised treatment strategies.

RNA 72
article thumbnail

Gepirone

New Drug Approvals

4] It was approved for the treatment of major depressive disorder in the United States in September 2023. [4] 4] It was approved for the treatment of major depressive disorder in the United States in September 2023. [4] 4] It was approved for the treatment of major depressive disorder in the United States in September 2023. [4]

FDA 62
article thumbnail

Navigating Regulatory Hurdles in Drug Development

DrugBank

Similarly, AstraZeneca’s gefitinib , an early targeted therapy for lung cancer, received a ccelerated approval in 2003 but later faced restricted use when follow-up studies failed to confirm its clinical benefit in a broader patient population.

article thumbnail

Inavolisib

New Drug Approvals

8] Therefore, it may serve as a new addition to combination therapy with conventional cancer treatment, such as chemotherapy. Combining inavolisib with palbociclib and fulvestrant might improve treatment of breast cancer. [14] Koyasu S (April 2003). Hz, 1H), 7.38 (br s, 1H), 7.18 (s, 1H), 7.00 (br s, 1H), 6.71 (t, J=55.9

FDA 57
article thumbnail

The Eternal Life and Art of Maxwell Ardeen

Codon

” By 2003, collaborators had cultivated frog meat grown from cells, preceding the scientific and market interests in cultured meats. The inheritors of such a worldview, the artist-researchers of The Tissue Culture and Art Project began exploring the artistic applications of tissue engineering in 1996.